Audentes Therapeutics, Inc. Marketable Securities (Current)
Audentes Therapeutics, Inc. had Marketable Securities (Current) of $287.90 million as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2019-11-07
- 2019-09-30: Marketable Securities, Current $287.90M.
- 2019-06-30: Marketable Securities, Current $279.60M.
- 2019-03-31: Marketable Securities, Current $241.90M.
| Period end | Marketable Securities, Current |
|---|---|
| 2019-09-30 | $287.90M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $279.60M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $241.90M 10-Q · filed 2019-05-08 |